Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Fin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MH

Go back to Akebia Announced Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis; Reports First Quarter 2020 Fin
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.92 +0.02 (2.22%)
Previous Close $0.90    52 Week High $13.20 
Open $0.89    52 Week Low $7.00 
Day High $0.96    P/E N/A 
Day Low $0.88    EPS $0.00 
Volume 3,009,710       

Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 34.70 --0 (-0%)
Previous Close $34.70    52 Week High $34.07 
Open $34.70    52 Week Low $21.84 
Day High $34.70    P/E N/A 
Day Low $34.70    EPS $0.00 
Volume 580,437       

Mitsubishi Tanabe Pharma Corporation Sponsored ADR (AMEX: MTZPY) Delayed: 18.60 --0 (-0%)
Previous Close $18.60    52 Week High $21.90 
Open $0.13    52 Week Low $15.98 
Day High $18.60    P/E N/A 
Day Low $18.60    EPS $0.00 
Volume 5,773